Literature DB >> 6839422

Effect of ovarian hormones on the induction of 1-methyl-1-nitrosourea-induced mammary cancer.

C J Grubbs, J C Peckham, K D McDonough.   

Abstract

The concomitant administration of 20 micrograms 17 beta-estradiol and 4 mg progesterone/injection (5 days/week) over a 40-day treatment period beginning 10 days after methylnitrosourea (MNU) treatment was as effective as ovariectomy in inhibiting mammary cancers (an 84% reduction from non-hormone treated rats). The primary action of the hormones must have been directed at preneoplastic cells since the hormones were not given until 10 days after MNU (a direct-acting carcinogen with a short half-life).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839422     DOI: 10.1093/carcin/4.4.495

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.

Authors:  R C Guzman; J Yang; L Rajkumar; G Thordarson; X Chen; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis.

Authors:  L Rajkumar; R C Guzman; J Yang; G Thordarson; F Talamantes; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

3.  A novel leupeptin-sensitive serine endopeptidase present in normal and malignant rat mammary tissues.

Authors:  I Eto; M D Bandy
Journal:  Mol Cell Biochem       Date:  1990-04-18       Impact factor: 3.396

4.  Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.

Authors:  Ronald A Lubet; Eva Szabo; Kenneth K Iwata; Stanley C Gill; Chris Tucker; Ann Bode; Vernon E Steele; M Margaret Juliana; Holly L Nicastro; Clinton J Grubbs
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26

5.  Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats.

Authors:  Edward W Blank; Po-Yin Wong; Rajkumar Lakshmanaswamy; Raphael Guzman; Satyabrata Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

Review 6.  Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.

Authors:  Leena Hilakivi-Clarke; Sonia de Assis; Anni Warri
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-02-08       Impact factor: 2.673

7.  Separation, purification and N-terminal sequence analysis of a novel leupeptin-sensitive serine endopeptidase present in chemically induced rat mammary tumour.

Authors:  I Eto; C J Grubbs
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

8.  Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomas.

Authors:  Kamel F Khazal; Temesgen Samuel; Donald L Hill; Clinton J Grubbs
Journal:  Anticancer Res       Date:  2013-04       Impact factor: 2.480

Review 9.  Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals.

Authors:  T Tsutsui; J C Barrett
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

10.  Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis.

Authors:  I H Russo; M Koszalka; P A Gimotty; J Russo
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.